Glioblastoma in children with NF1: the need for basic research.

David N. Korones, Amy Smith, Nicholas Foreman, Eric Bouffet, Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas Pediatric Blood & Cancer. ,vol. 47, pp. 37- 41 ,(2006) , 10.1002/PBC.20510

Alan E. Guttmacher, Amy L. McGuire, Bruce Ponder, Kári Stefánsson, Personalized genomic information: preparing for the future of genetic medicine Nature Reviews Genetics. ,vol. 11, pp. 161- 165 ,(2010) , 10.1038/NRG2735

Antonio Ruggiero, Graziella Cefalo, ML Garre, Maura Massimino, Cesare Colosimo, Giorgio Attinà, Ilaria Lazzareschi, Palma Maurizi, Vita Ridola, Giorgio Mazzarella, Massimo Caldarelli, C Di Rocco, E Madon, ME Abate, Anna Clerico, Alessandro Sandri, Riccardo Riccardi, None, Phase II trial of temozolomide in children with recurrent high-grade glioma Journal of Neuro-oncology. ,vol. 77, pp. 89- 94 ,(2006) , 10.1007/S11060-005-9011-2

Biplab Dasgupta, David H Gutmann, Neurofibromatosis 1: closing the GAP between mice and men. Current Opinion in Genetics & Development. ,vol. 13, pp. 20- 27 ,(2003) , 10.1016/S0959-437X(02)00015-1

S. Baruchel, M. Diezi, D. Hargrave, D. Stempak, J. Gammon, A. Moghrabi, M.J. Coppes, C.V. Fernandez, E. Bouffet, Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours. European Journal of Cancer. ,vol. 42, pp. 2335- 2342 ,(2006) , 10.1016/J.EJCA.2006.03.023

Joshua T. Dilworth, Janice M. Kraniak, Jonathan W. Wojtkowiak, Richard A. Gibbs, Richard F. Borch, Michael A. Tainsky, John J. Reiners, Raymond R. Mattingly, Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1. Biochemical Pharmacology. ,vol. 72, pp. 1485- 1492 ,(2006) , 10.1016/J.BCP.2006.04.010

Roger Stupp, Warren P. Mason, Martin J. van den Bent, Michael Weller, Barbara Fisher, Martin J.B. Taphoorn, Karl Belanger, Alba A. Brandes, Christine Marosi, Ulrich Bogdahn, Jürgen Curschmann, Robert C. Janzer, Samuel K. Ludwin, Thierry Gorlia, Anouk Allgeier, Denis Lacombe, J. Gregory Cairncross, Elizabeth Eisenhauer, René O. Mirimanoff, Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma The New England Journal of Medicine. ,vol. 352, pp. 987- 996 ,(2005) , 10.1056/NEJMOA043330

Regina I. Jakacki, Allan Yates, Susan M. Blaney, Tianni Zhou, Robert Timmerman, Ashish M. Ingle, Lynda Flom, Michael D. Prados, Peter C. Adamson, Ian F. Pollack, A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood Neuro-oncology. ,vol. 10, pp. 569- 576 ,(2008) , 10.1215/15228517-2008-019

Hilde Brems, Eline Beert, Thomy de Ravel, Eric Legius, Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1 Lancet Oncology. ,vol. 10, pp. 508- 515 ,(2009) , 10.1016/S1470-2045(09)70033-6

Martin H. Cohen, John R. Johnson, Richard Pazdur, U.S. Food and Drug Administration Drug Approval Summary: Conversion of Imatinib Mesylate (STI571; Gleevec) Tablets from Accelerated Approval to Full Approval Clinical Cancer Research. ,vol. 11, pp. 6767- 6771 ,(2005) , 10.1158/1078-0432.CCR-05-0722